Type 3 IP3 receptor: Its structure, functions, and related disease implications

References

• Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000 Oct;1(1):11–15. doi: 10.1038/35036035
   PubMed Web of Science ®Google Scholar
• Zhai M, Yang D, Yi W, et al. Involvement of calcium channels in the regulation of adipogenesis. Adipocyte. 2020 Dec;9(1):132–141. doi: 10.1080/21623945.2020.1738792
   PubMed Web of Science ®Google Scholar
• Clapham DE. Calcium signaling. Cell. 2007 Dec 14;131(6):1047–1058. doi: 10.1016/j.cell.2007.11.028
   PubMed Web of Science ®Google Scholar
• Szewczyk A, Saczko J, Kulbacka J. Apoptosis as the main type of cell death induced by calcium electroporation in rhabdomyosarcoma cells. Bioelectrochemistry. 2020 Dec;136:107592. doi: 10.1016/j.bioelechem.2020.107592
   PubMed Web of Science ®Google Scholar
• Bootman MD, Bultynck G. Fundamentals of cellular calcium signaling: a primer. Cold Spring Harb Perspect Biol. 2020 Jan 2;12(1):a038802. doi: 10.1101/cshperspect.a038802
   PubMed Web of Science ®Google Scholar
• Rosa N, Sneyers F, Parys JB et al. Type 3 IP(3) receptors: the chameleon in cancer. Int Rev Cell Mol Biol. 2020;351:101–148. doi:10.1016/bs.ircmb.2020.02.003
   PubMed Web of Science ®Google Scholar
• Hamada K, Mikoshiba K. IP 3 receptor plasticity underlying diverse functions. Annu Rev Physiol. 2020 Feb 10;82(1):151–176. doi: 10.1146/annurev-physiol-021119-034433
   PubMedGoogle Scholar
• Foskett JK, White C, Cheung KH, et al. Inositol trisphosphate receptor Ca2+ release channels. Physiol Rev. 2007 Apr;87(2):593–658. doi: 10.1152/physrev.00035.2006
   PubMed Web of Science ®Google Scholar
• Ivanova H, Vervliet T, Missiaen L, et al. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival. Biochim Biophys Acta. 2014 Oct;1843(10):2164–2183. doi: 10.1016/j.bbamcr.2014.03.007
   PubMed Web of Science ®Google Scholar
• Taylor CW, Genazzani AA, Morris SA. Expression of inositol trisphosphate receptors. Cell Calcium. 1999 Dec;26(6):237–251. doi: 10.1054/ceca.1999.0090
   PubMed Web of Science ®Google Scholar
• Vermassen E, Parys JB, Mauger JP. Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol Cell. 2004 Feb;96(1):3–17. doi: 10.1016/j.biolcel.2003.11.004
   PubMed Web of Science ®Google Scholar
• De Smedt H, Missiaen L, Parys JB, et al. Determination of relative amounts of inositol trisphosphate receptor mRNA isoforms by ratio polymerase chain reaction. J Biol Chem. 1994 Aug 26;269(34):21691–21698. doi: 10.1016/S0021-9258(17)31861-6
   PubMed Web of Science ®Google Scholar
• De Smedt H, Missiaen L, Parys JB, et al. Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. Biochem J. 1997 Mar 1;322(Pt 2):575–583. doi: 10.1042/bj3220575
   PubMedGoogle Scholar
• Perez PJ, Ramos-Franco J, Fill M, et al. Identification and functional reconstitution of the type 2 inositol 1,4,5-trisphosphate receptor from ventricular cardiac myocytes. J Biol Chem. 1997 Sep 19;272(38):23961–23969. doi: 10.1074/jbc.272.38.23961
   PubMed Web of Science ®Google Scholar
• Hirata K, Pusl T, O’Neill AF, et al. The type II inositol 1,4,5-trisphosphate receptor can trigger Ca2+ waves in rat hepatocytes. Gastroenterology. 2002 Apr;122(4):1088–1100. doi: 10.1053/gast.2002.32363
   PubMed Web of Science ®Google Scholar
• Kerkhofs M, Seitaj B, Ivanova H, et al. Pathophysiological consequences of isoform-specific IP(3) receptor mutations. Biochim Biophys Acta, Mol Cell Res. 2018 Nov;1865(11 Pt B):1707–1717. doi: 10.1016/j.bbamcr.2018.06.004
   PubMed Web of Science ®Google Scholar
• Vervloessem T, Yule DI, Bultynck G, et al. The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca(2)(+)-release channel. Biochim Biophys Acta. 2015 Sep;1853(9):1992–2005. doi: 10.1016/j.bbamcr.2014.12.006
   PubMed Web of Science ®Google Scholar
• Newton CL, Mignery GA, Sudhof TC. Co-expression in vertebrate tissues and cell lines of multiple inositol 1,4,5-trisphosphate (InsP3) receptors with distinct affinities for InsP3. J Biol Chem. 1994 Nov 18;269(46):28613–28619. doi: 10.1016/S0021-9258(19)61949-6
   PubMed Web of Science ®Google Scholar
• Kuchay S, Giorgi C, Simoneschi D, et al. PTEN counteracts FBXL2 to promote IP3R3- and Ca(2+)-mediated apoptosis limiting tumour growth. Nature. 2017 Jun 22;546(7659):554–558. doi: 10.1038/nature22965
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang L, Yue Y, et al. ITPR3 facilitates tumor growth, metastasis and stemness by inducing the NF-kB/CD44 pathway in urinary bladder carcinoma. J Exp Clin Cancer Res. 2021 Feb 11;40(1):65. doi: 10.1186/s13046-021-01866-1
   PubMed Web of Science ®Google Scholar
• Roach JC, Deutsch K, Li S, et al. Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. Am J Hum Genet. 2006 Oct;79(4):614–627. doi: 10.1086/507876
   PubMed Web of Science ®Google Scholar
• Yeung ATY, Choi YH, Lee AHY, et al. A genome-wide knockout screen in human macrophages identified host factors modulating Salmonella infection. MBio. 2019 Oct 8;10(5):10–128. doi: 10.1128/mBio.02169-19
   Web of Science ®Google Scholar
• Miyachi K, Iwai M, Asada K, et al. Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjogren’s syndrome and other systemic rheumatic diseases. Mod Rheumatol. 2007;17(2):137–143. doi: 10.3109/s10165-006-0555-6
   PubMedGoogle Scholar
• Mo XB, Sun YH, Zhang YH et al. Integrative analysis highlighted susceptibility genes for rheumatoid arthritis. Int Immunopharmacol. 2020 Sep;86:106716. doi:10.1016/j.intimp.2020.106716
   PubMed Web of Science ®Google Scholar
• Oishi T, Iida A, Otsubo S, et al. A functional SNP in the NKX2.5-binding site of ITPR3 promoter is associated with susceptibility to systemic lupus erythematosus in Japanese population. J Hum Genet. 2008;53(2):151–162. doi: 10.1007/s10038-007-0233-3
   PubMed Web of Science ®Google Scholar
• Nguyen PH, Lutter EI, Hackstadt T, et al. Chlamydia trachomatis inclusion membrane protein MrcA interacts with the inositol 1,4,5-trisphosphate receptor type 3 (ITPR3) to regulate extrusion formation. PLOS Pathog. 2018 Mar;14(3):e1006911. doi: 10.1371/journal.ppat.1006911
   PubMed Web of Science ®Google Scholar
• Maranto AR. Primary structure, ligand binding, and localization of the human type 3 inositol 1,4,5-trisphosphate receptor expressed in intestinal epithelium. J Biol Chem. 1994 Jan 14;269(2):1222–1230. doi: 10.1016/S0021-9258(17)42246-0
   PubMed Web of Science ®Google Scholar
• Mignery GA, Sudhof TC. The ligand binding site and transduction mechanism in the inositol-1,4,5-triphosphate receptor. EMBO J. 1990 Dec;9(12):3893–3898. doi: 10.1002/j.1460-2075.1990.tb07609.x
   PubMed Web of Science ®Google Scholar
• Iwai M, Michikawa T, Bosanac I, et al. Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors. J Biol Chem. 2007 Apr 27;282(17):12755–12764. doi: 10.1074/jbc.M609833200
   PubMed Web of Science ®Google Scholar
• Uchida K, Miyauchi H, Furuichi T, et al. Critical regions for activation gating of the inositol 1,4,5-trisphosphate receptor. J Biol Chem. 2003 May 9;278(19):16551–16560. doi: 10.1074/jbc.M300646200
   PubMed Web of Science ®Google Scholar
• Patterson RL, Boehning D, Snyder SH. Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu Rev Biochem. 2004;73(1):437–465. doi: 10.1146/annurev.biochem.73.071403.161303
   PubMedGoogle Scholar
• Mikoshiba K. IP3 receptor/Ca2+ channel: from discovery to new signaling concepts. J Neurochem. 2007 Sep;102(5):1426–1446. doi: 10.1111/j.1471-4159.2007.04825.x
   PubMed Web of Science ®Google Scholar
• Serysheva II. Toward a high-resolution structure of IP(3)R channel. Cell Calcium. 2014 Sep;56(3):125–132. doi: 10.1016/j.ceca.2014.08.002
   PubMed Web of Science ®Google Scholar
• Bosanac I, Michikawa T, Mikoshiba K, et al. Structural insights into the regulatory mechanism of IP3 receptor. Biochim Biophys Acta. 2004 Dec 6;1742(1–3):89–102. doi: 10.1016/j.bbamcr.2004.09.016
   PubMed Web of Science ®Google Scholar
• Miyawaki A, Furuichi T, Ryou Y, et al. Structure-function relationships of the mouse inositol 1,4,5-trisphosphate receptor. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4911–4915. doi: 10.1073/pnas.88.11.4911
   PubMed Web of Science ®Google Scholar
• Galvan DL, Borrego-Diaz E, Perez PJ, et al. Subunit oligomerization, and topology of the inositol 1,4, 5-trisphosphate receptor. J Biol Chem. 1999 Oct 8;274(41):29483–29492. doi: 10.1074/jbc.274.41.29483
   PubMed Web of Science ®Google Scholar
• Fan G, Baker ML, Wang Z, et al. Gating machinery of InsP3R channels revealed by electron cryomicroscopy. Nature. 2015 Nov 19;527(7578):336–341. doi: 10.1038/nature15249
   PubMed Web of Science ®Google Scholar
• Paknejad N, Hite RK. Structural basis for the regulation of inositol trisphosphate receptors by Ca(2+) and IP(3). Nat Struct Mol Biol. 2018 Aug;25(8):660–668. doi: 10.1038/s41594-018-0089-6
   PubMed Web of Science ®Google Scholar
• Azumaya CM, Linton EA, Risener CJ, et al. Cryo-EM structure of human type-3 inositol triphosphate receptor reveals the presence of a self-binding peptide that acts as an antagonist. J Biol Chem. 2020 Feb 7;295(6):1743–1753. doi: 10.1074/jbc.RA119.011570
   PubMed Web of Science ®Google Scholar
• Schmitz EA, Takahashi H, Karakas E. Structural basis for activation and gating of IP(3) receptors. Nat Commun. 2022 Mar 17;13(1):1408. doi: 10.1038/s41467-022-29073-2
   PubMed Web of Science ®Google Scholar
• Fan G, Baker MR, Wang Z, et al. Cryo-EM reveals ligand induced allostery underlying InsP(3)R channel gating. Cell Res. 2018 Dec;28(12):1158–1170. doi: 10.1038/s41422-018-0108-5
   PubMed Web of Science ®Google Scholar
• Mendes CC, Gomes DA, Thompson M, et al. The type III inositol 1,4,5-trisphosphate receptor preferentially transmits apoptotic Ca2+ signals into mitochondria. J Biol Chem. 2005 Dec 9;280(49):40892–40900. doi: 10.1074/jbc.M506623200
   PubMed Web of Science ®Google Scholar
• Sharp AH, Nucifora FC Jr., Blondel O, et al. Differential cellular expression of isoforms of inositol 1,4,5-triphosphate receptors in neurons and glia in brain. J Comp Neurol. 1999 Apr 5;406(2):207–220. doi: 10.1002/(SICI)1096-9861(19990405)406:2<207:AID-CNE6>3.0.CO;2-7
   PubMed Web of Science ®Google Scholar
• Ramos-Lopez O, Riezu-Boj JI, Milagro FI, et al. Dopamine gene methylation patterns are associated with obesity markers and carbohydrate intake. Brain Behav. 2018 Aug;8(8):e01017. doi: 10.1002/brb3.1017
   PubMed Web of Science ®Google Scholar
• Bononi A, Giorgi C, Patergnani S, et al. BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation. Nature. 2017 Jun 22;546(7659):549–553. doi: 10.1038/nature22798
   PubMed Web of Science ®Google Scholar
• Liao C, Zhang Y, Fan C, et al. Identification of BBOX1 as a therapeutic target in Triple-negative breast cancer. Cancer Discov. 2020 Nov;10(11):1706–1721. doi: 10.1158/2159-8290.CD-20-0288
   PubMed Web of Science ®Google Scholar
• Kuchay S, Saeed M, Giorgi C, et al. NS5A promotes constitutive degradation of IP3R3 to counteract apoptosis induced by hepatitis C virus. Cell Rep. 2018 Oct 23;25(4):833–840 e3. doi: 10.1016/j.celrep.2018.09.088
   PubMed Web of Science ®Google Scholar
• Ueasilamongkol P, Khamphaya T, Guerra MT, et al. Type 3 inositol 1,4,5-trisphosphate receptor is increased and enhances malignant properties in cholangiocarcinoma. Hepatology. 2020 Feb;71(2):583–599. doi: 10.1002/hep.30839
   PubMed Web of Science ®Google Scholar
• Wei W, Huang W, Yue J. Requirement of IP3 receptor 3 (IP3R3) in nitric oxide induced cardiomyocyte differentiation of mouse embryonic stem cells. Exp Cell Res. 2016 Aug 1;346(1):9–16. doi: 10.1016/j.yexcr.2016.06.016
   PubMed Web of Science ®Google Scholar
• Mound A, Rodat-Despoix L, Bougarn S, et al. Molecular interaction and functional coupling between type 3 inositol 1,4,5-trisphosphate receptor and BKCa channel stimulate breast cancer cell proliferation. Eur J Cancer. 2013 Nov;49(17):3738–3751. doi: 10.1016/j.ejca.2013.07.013
   PubMed Web of Science ®Google Scholar
• Dos Santos ML, Franca A, Lima Filho ACM, et al. Inositol 1,4,5-trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma. Oncol Lett. 2022 Jan;23(1):32. doi: 10.3892/ol.2021.13150
   PubMed Web of Science ®Google Scholar
• Avalle L, Camporeale A, Morciano G, et al. STAT3 localizes to the ER, acting as a gatekeeper for ER-mitochondrion Ca(2+) fluxes and apoptotic responses. Cell Death Differ. 2019 May;26(5):932–942. doi: 10.1038/s41418-018-0171-y
   PubMed Web of Science ®Google Scholar
• Rezuchova I, Hudecova S, Soltysova A, et al. Type 3 inositol 1,4,5-trisphosphate receptor has antiapoptotic and proliferative role in cancer cells. Cell Death Dis. 2019 Feb 22;10(3):186. doi: 10.1038/s41419-019-1433-4
   PubMedGoogle Scholar
• Yang YD, Li MM, Xu G, et al. Nogo-B receptor directs mitochondria-associated membranes to regulate vascular smooth muscle cell proliferation. Int J Mol Sci. 2019 May 10;20(9):2319. doi: 10.3390/ijms20092319
   PubMed Web of Science ®Google Scholar
• Mound A, Vautrin-Glabik A, Foulon A, et al. Downregulation of type 3 inositol (1,4,5)-trisphosphate receptor decreases breast cancer cell migration through an oscillatory Ca(2+) signal. Oncotarget. 2017 Sep 22;8(42):72324–72341. doi: 10.18632/oncotarget.20327
   PubMedGoogle Scholar
• Shibao K, Fiedler MJ, Nagata J, et al. The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma. Cell Calcium. 2010 Dec;48(6):315–323. doi: 10.1016/j.ceca.2010.09.005
   PubMed Web of Science ®Google Scholar
• Liang J, Wang YJ, Tang Y, et al. Type 3 inositol 1,4,5-trisphosphate receptor negatively regulates apoptosis during mouse embryonic stem cell differentiation. Cell Death Differ. 2010 Jul;17(7):1141–1154. doi: 10.1038/cdd.2009.209
   PubMed Web of Science ®Google Scholar
• Kang SS, Han KS, Ku BM, et al. Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res. 2010 Feb 1;70(3):1173–1183. doi: 10.1158/0008-5472.CAN-09-2886
   PubMed Web of Science ®Google Scholar
• Nagaleekar VK, Diehl SA, Juncadella I, et al. IP3 receptor-mediated Ca2+ release in naive CD4 T cells dictates their cytokine program. J Immunol. 2008 Dec 15;181(12):8315–8322. doi: 10.4049/jimmunol.181.12.8315
   PubMed Web of Science ®Google Scholar
• Futatsugi A, Ebisui E, Mikoshiba K. Type 2 and type 3 inositol 1,4,5-trisphosphate (IP3) receptors promote the differentiation of granule cell precursors in the postnatal cerebellum. J Neurochem. 2008 May;105(4):1153–1164. doi: 10.1111/j.1471-4159.2008.05221.x
   PubMed Web of Science ®Google Scholar
• Xue Y, Morris JL, Yang K, et al. SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria. Nat Commun. 2021 Sep 13;12(1):5404. doi: 10.1038/s41467-021-25260-9
   PubMed Web of Science ®Google Scholar
• Florea AM, Varghese E, McCallum JE, et al. Calcium-regulatory proteins as modulators of chemotherapy in human neuroblastoma. Oncotarget. 2017 Apr 4;8(14):22876–22893. doi: 10.18632/oncotarget.15283
   PubMedGoogle Scholar
• Vautrin-Glabik A, Botia B, Kischel P, et al. IP(3)R3 silencing induced actin cytoskeletal reorganization through ARHGAP18/RhoA/mDia1/FAK pathway in breast cancer cell lines. Biochim Biophys Acta, Mol Cell Res. 2018 Jul;1865(7):945–958. doi: 10.1016/j.bbamcr.2018.04.002
   PubMed Web of Science ®Google Scholar
• Geyer M, Huang F, Sun Y, et al. Microtubule-associated protein EB3 regulates IP3 receptor clustering and Ca(2+) signaling in endothelial cells. Cell Rep. 2015 Jul 7;12(1):79–89. doi: 10.1016/j.celrep.2015.06.001
   PubMed Web of Science ®Google Scholar
• Bartok A, Weaver D, Golenar T, et al. IP(3) receptor isoforms differently regulate ER-mitochondrial contacts and local calcium transfer. Nat Commun. 2019 Aug 19;10(1):3726. doi: 10.1038/s41467-019-11646-3
   PubMedGoogle Scholar
• Hedskog L, Pinho CM, Filadi R, et al. Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer’s disease and related models. Proc Natl Acad Sci U S A. 2013 May 7;110(19):7916–7921. doi: 10.1073/pnas.1300677110
   PubMed Web of Science ®Google Scholar
• Mak DO, McBride S, Foskett JK. Regulation by Ca2+ and inositol 1,4,5-trisphosphate (InsP3) of single recombinant type 3 InsP3 receptor channels. Ca2+ activation uniquely distinguishes types 1 and 3 insp3 receptors. J Gen Physiol. 2001 May;117(5):435–446. doi: 10.1085/jgp.117.5.435
   PubMed Web of Science ®Google Scholar
• Tu H, Wang Z, Bezprozvanny I. Modulation of mammalian inositol 1,4,5-trisphosphate receptor isoforms by calcium: a role of calcium sensor region. Biophys J. 2005 Feb;88(2):1056–1069. doi: 10.1529/biophysj.104.049601
   PubMed Web of Science ®Google Scholar
• Chaloux B, Caron AZ, Guillemette G. Protein kinase a increases the binding affinity and the Ca2+ release activity of the inositol 1,4,5-trisphosphate receptor type 3 in RINm5F cells. Biol Cell. 2007 Jul;99(7):379–388. doi: 10.1042/BC20060121
   PubMed Web of Science ®Google Scholar
• Betzenhauser MJ, Wagner LE 2nd, Iwai M, et al. ATP modulation of Ca2+ release by type-2 and type-3 inositol (1, 4, 5)-triphosphate receptors. Differing ATP sensitivities and molecular determinants of action. J Biol Chem. 2008 Aug 1;283(31):21579–21587. doi: 10.1074/jbc.M801680200
   PubMed Web of Science ®Google Scholar
• Maes K, Missiaen L, De Smet P, et al. Differential modulation of inositol 1,4,5-trisphosphate receptor type 1 and type 3 by ATP. Cell Calcium. 2000 May;27(5):257–267. doi: 10.1054/ceca.2000.0121
   PubMed Web of Science ®Google Scholar
• Tu H, Wang Z, Nosyreva E, et al. Functional characterization of mammalian inositol 1,4,5-trisphosphate receptor isoforms. Biophys J. 2005 Feb;88(2):1046–1055. doi: 10.1529/biophysj.104.049593
   PubMed Web of Science ®Google Scholar
• Boehning D, Patterson RL, Sedaghat L, et al. Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol. 2003 Dec;5(12):1051–1061. doi: 10.1038/ncb1063
   PubMed Web of Science ®Google Scholar
• Eckenrode EF, Yang J, Velmurugan GV, et al. Apoptosis protection by mcl-1 and bcl-2 modulation of inositol 1,4,5-trisphosphate receptor-dependent Ca2+ signaling. J Biol Chem. 2010 Apr 30;285(18):13678–13684. doi: 10.1074/jbc.M109.096040
   PubMed Web of Science ®Google Scholar
• Nguyen N, Francoeur N, Chartrand V, et al. Insulin promotes the association of heat shock protein 90 with the inositol 1,4,5-trisphosphate receptor to dampen its Ca2+ release activity. Endocrinology. 2009 May;150(5):2190–2196. doi: 10.1210/en.2008-1167
   PubMed Web of Science ®Google Scholar
• Lorca RA, Prabagaran M, England SK. Functional insights into modulation of BKCa channel activity to alter myometrial contractility. Front Physiol. 2014;5:289. doi: 10.3389/fphys.2014.00289
   PubMed Web of Science ®Google Scholar
• Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Bio. 2010 Jan 11;188(1):11–19. doi: 10.1083/jcb.200909003
   PubMed Web of Science ®Google Scholar
• Hedberg ML, Goh G, Chiosea SI, et al. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma. J Clin Invest. 2016 Jan;126(1):169–180. doi: 10.1172/JCI82066
   PubMed Web of Science ®Google Scholar
• Yang YC, Chang TY, Chen TC, et al. ITPR3 gene haplotype is associated with cervical squamous cell carcinoma risk in Taiwanese women. Oncotarget. 2017 Feb 7;8(6):10085–10090. doi: 10.18632/oncotarget.14341
   PubMedGoogle Scholar
• Huang YC, Lin YJ, Chang JS, et al. Single nucleotide polymorphism rs2229634 in the ITPR3 gene is associated with the risk of developing coronary artery aneurysm in children with Kawasaki disease. Int J Immunogenet. 2010 Dec;37(6):439–443. doi: 10.1111/j.1744-313X.2010.00943.x
   PubMed Web of Science ®Google Scholar
• Ronkko J, Molchanova S, Revah-Politi A, et al. Dominant mutations in ITPR3 cause Charcot-Marie-Tooth disease. Ann Clin Transl Neurol. 2020 Oct;7(10):1962–1972. doi: 10.1002/acn3.51190
   PubMed Web of Science ®Google Scholar
• Wu Y, Liu Z, Tang D et al. Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients. Transl Res. 2021 Jul;233:92–103. doi:10.1016/j.trsl.2020.12.009
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou J, Jiang Y, et al. Inositol 1,4,5-trisphosphate receptor gene variants are related to the risk of breast cancer in a Chinese population. J Gene Med. 2023 Feb;25(2):e3463. doi: 10.1002/jgm.3463
   PubMed Web of Science ®Google Scholar
• Schabhuttl M, Wieland T, Senderek J, et al. Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges. J Neurol. 2014 May;261(5):970–982. doi: 10.1007/s00415-014-7289-8
   PubMed Web of Science ®Google Scholar
• Nakabayashi K, Tajima A, Yamamoto K, et al. Identification of independent risk loci for Graves’ disease within the MHC in the Japanese population. J Hum Genet. 2011 Nov;56(11):772–778. doi: 10.1038/jhg.2011.99
   PubMed Web of Science ®Google Scholar
• Cotsapas C, Speliotes EK, Hatoum IJ, et al. Common body mass index-associated variants confer risk of extreme obesity. Hum Mol Genet. 2009 Sep 15;18(18):3502–3507. doi: 10.1093/hmg/ddp292
   PubMed Web of Science ®Google Scholar
• Kichaev G, Bhatia G, Loh PR, et al. Leveraging polygenic functional enrichment to improve GWAS power. Am J Hum Genet. 2019 Jan 3;104(1):65–75. doi: 10.1016/j.ajhg.2018.11.008
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhu X, Liu CL, et al. Shared genetics of asthma and mental health disorders: a large-scale genome-wide cross-trait analysis. Eur Respir J. 2019 Dec;54(6):1901507. doi: 10.1183/13993003.01507-2019
   PubMed Web of Science ®Google Scholar
• Ferreira MA, Vonk JM, Baurecht H, et al. Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology. Nat Genet. 2017 Dec;49(12):1752–1757. doi: 10.1038/ng.3985
   PubMed Web of Science ®Google Scholar
• Heit JA, Armasu SM, McCauley BM, et al. Identification of unique venous thromboembolism-susceptibility variants in African-Americans. Thromb Haemost. 2017 Apr 3;117(4):758–768. doi: 10.1160/TH16-08-0652
   PubMed Web of Science ®Google Scholar
• Wang Y, Bos SD, Harbo HF, et al. Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors. Mult Scler. 2016 Dec;22(14):1783–1793. doi: 10.1177/1352458516635873
   PubMed Web of Science ®Google Scholar
• Takeuchi F, Yokota M, Yamamoto K, et al. Genome-wide association study of coronary artery disease in the Japanese. Eur J Hum Genet. 2012 Mar;20(3):333–340. doi: 10.1038/ejhg.2011.184
   PubMed Web of Science ®Google Scholar
• Padyukov L, Seielstad M, Ong RT, et al. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis. 2011 Feb;70(2):259–265. doi: 10.1136/ard.2009.126821
   PubMed Web of Science ®Google Scholar
• Mbarek H, Ochi H, Urabe Y, et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet. 2011 Oct 1;20(19):3884–3892. doi: 10.1093/hmg/ddr301
   PubMed Web of Science ®Google Scholar
• Turnbull C, Rapley EA, Seal S, et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet. 2010 Jul;42(7):604–607. doi: 10.1038/ng.607
   PubMed Web of Science ®Google Scholar
• Gregersen PK, Amos CI, Lee AT, et al. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet. 2009 Jul;41(7):820–823. doi: 10.1038/ng.395
   PubMed Web of Science ®Google Scholar
• Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis–a genomewide study. N Engl J Med. 2007 Sep 20;357(12):1199–1209. doi: 10.1056/NEJMoa073491
   PubMed Web of Science ®Google Scholar
• Reddy MV, Wang H, Liu S, et al. Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population. Genes Immun. 2011 Apr;12(3):208–212. doi: 10.1038/gene.2010.70
   PubMed Web of Science ®Google Scholar
• Neumann J, Van Nieuwenhove E, Terry LE, et al. Disrupted Ca(2+) homeostasis and immunodeficiency in patients with functional IP(3) receptor subtype 3 defects. Cell Mol Immunol. 2023 Jan;20(1):11–25. doi: 10.1038/s41423-022-00928-4
   PubMed Web of Science ®Google Scholar
• Horjus J, van Mourik-Banda T, Heerings MAP, et al. Whole exome sequencing in multi-incident families identifies novel candidate genes for multiple sclerosis. Int J Mol Sci. 2022 Sep 28;23(19):11461. doi: 10.3390/ijms231911461
   PubMed Web of Science ®Google Scholar
• Yucesoy B, Talzhanov Y, Michael Barmada M, et al. Association of MHC region SNPs with irritant susceptibility in healthcare workers. J Immunotoxicol. 2016 Sep;13(5):738–744. doi: 10.3109/1547691X.2016.1173135
   PubMed Web of Science ®Google Scholar
• Freeman SC, Malik A, Basit H. Physiology, exocrine gland. Treasure Island (FL). StatPearls; 2022.
   Google Scholar
• Ahuja M, Chung WY, Lin WY, et al. Ca2+Signaling in exocrine cells. Cold Spring Harb Perspect Biol. 2020 May 1;12(5):a035279. doi: 10.1101/cshperspect.a035279
   PubMed Web of Science ®Google Scholar
• Inaba T, Hisatsune C, Sasaki Y, et al. Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye. PLoS One. 2014;9(6):e99205. doi: 10.1371/journal.pone.0099205
   PubMed Web of Science ®Google Scholar
• Teos LY, Zhang Y, Cotrim AP, et al. IP3R deficit underlies loss of salivary fluid secretion in Sjögren’s syndrome. Sci Rep. 2015 Sep 14;5(1):13953. doi: 10.1038/srep13953
   PubMedGoogle Scholar
• Fukuda N, Shirasu M, Sato K, et al. Decreased olfactory mucus secretion and nasal abnormality in mice lacking type 2 and type 3 IP3 receptors. Eur J Neurosci. 2008 May;27(10):2665–2675. doi: 10.1111/j.1460-9568.2008.06240.x
   PubMed Web of Science ®Google Scholar
• Hirata K, Dufour JF, Shibao K, et al. Regulation of Ca(2+) signaling in rat bile duct epithelia by inositol 1,4,5-trisphosphate receptor isoforms. Hepatology. 2002 Aug;36(2):284–296. doi: 10.1053/jhep.2002.34432
   PubMed Web of Science ®Google Scholar
• Shibao K, Hirata K, Robert ME, et al. Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis. Gastroenterology. 2003 Oct;125(4):1175–1187. doi: 10.1016/S0016-5085(03)01201-0
   PubMed Web of Science ®Google Scholar
• Weerachayaphorn J, Amaya MJ, Spirli C, et al. Nuclear factor, erythroid 2-like 2 regulates expression of type 3 inositol 1,4,5-trisphosphate receptor and calcium signaling in cholangiocytes. Gastroenterology. 2015 Jul;149(1):211–222 e10. doi: 10.1053/j.gastro.2015.03.014
   PubMed Web of Science ®Google Scholar
• Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015 Oct;278(4):369–395. doi: 10.1111/joim.12395
   PubMed Web of Science ®Google Scholar
• Tolosa E, Garrido A, Scholz SW, et al. Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol. 2021 May;20(5):385–397. doi: 10.1016/S1474-4422(21)00030-2
   PubMed Web of Science ®Google Scholar
• Zhang L, Shimoji M, Thomas B, et al. Mitochondrial localization of the Parkinson’s disease related protein DJ-1: implications for pathogenesis. Hum Mol Genet. 2005 Jul 15;14(14):2063–2073. doi: 10.1093/hmg/ddi211
   PubMed Web of Science ®Google Scholar
• Liu Y, Ma X, Fujioka H, et al. DJ-1 regulates the integrity and function of ER-mitochondria association through interaction with IP3R3-Grp75-VDAC1. Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25322–25328. doi: 10.1073/pnas.1906565116
   PubMed Web of Science ®Google Scholar
• Laura M, Pipis M, Rossor AM, et al. Charcot-Marie-Tooth disease and related disorders: an evolving landscape. Curr Opin Neurol. 2019 Oct;32(5):641–650. doi: 10.1097/WCO.0000000000000735
   PubMed Web of Science ®Google Scholar
• Papakostas GI. Major depressive disorder: psychosocial impairment and key considerations in functional improvement. Am J Manag Care. 2009 Dec;15(11 Suppl):S316–21.
   PubMedGoogle Scholar
• Wu W, Howard D, Sibille E, et al. Differential and spatial expression meta-analysis of genes identified in genome-wide association studies of depression. Transl Psychiatry. 2021 Jan 4;11(1):8. doi: 10.1038/s41398-020-01127-3
   PubMed Web of Science ®Google Scholar
• Hisatsune C, Yasumatsu K, Takahashi-Iwanaga H, et al. Abnormal taste perception in mice lacking the type 3 inositol 1,4,5-trisphosphate receptor. J Biol Chem. 2007 Dec 21;282(51):37225–37231. doi: 10.1074/jbc.M705641200
   PubMed Web of Science ®Google Scholar
• Shindo Y, Kim MR, Miura H, et al. Lrmp/Jaw1 is expressed in sweet, bitter, and umami receptor-expressing cells. Chem Senses. 2010 Feb;35(2):171–177. doi: 10.1093/chemse/bjp097
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hoon MA, Chandrashekar J, et al. Coding of sweet, bitter, and umami tastes: different receptor cells sharing similar signaling pathways. Cell. 2003 Feb 7;112(3):293–301. doi: 10.1016/S0092-8674(03)00071-0
   PubMed Web of Science ®Google Scholar
• Liu WJ, Yang J. Developmental expression of inositol 1, 4, 5-trisphosphate receptor in the post-natal rat cochlea. Eur J Histochem. 2015 Apr 21;59(2):2486. doi: 10.4081/ejh.2015.2486
   PubMed Web of Science ®Google Scholar
• Murillo A, Vera-Estrella R, Barkla BJ, et al. Identification of host cell factors associated with astrovirus replication in caco-2 cells. J Virol. 2015 Oct;89(20):10359–10370. doi: 10.1128/JVI.01225-15
   PubMed Web of Science ®Google Scholar
• Zheng W, Bai X, Zhou Y, et al. Transcriptional ITPR3 as potential targets and biomarkers for human pancreatic cancer. Aging. 2022 May 17;14(10):4425–4444. doi: 10.18632/aging.204080
   PubMedGoogle Scholar
• Foulon A, Rybarczyk P, Jonckheere N, et al. Inositol (1,4,5)-trisphosphate receptors in invasive breast cancer: a New prognostic tool? Int J Mol Sci. 2022 Mar 9;23(6):2962. doi: 10.3390/ijms23062962
   PubMed Web of Science ®Google Scholar
• Bunbanjerdsuk S, Vorasan N, Saethang T, et al. Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma. Mod Pathol. 2019 Jul;32(7):943–956. doi: 10.1038/s41379-019-0211-2
   PubMed Web of Science ®Google Scholar
• Rodrigues MA, Gomes DA, Cosme AL et al. Inositol 1,4,5-trisphosphate receptor type 3 (ITPR3) is overexpressed in cholangiocarcinoma and its expression correlates with S100 calcium-binding protein A4 (S100A4). Biomed Pharmacother. 2022 Jan;145:112403. doi:10.1016/j.biopha.2021.112403
   PubMed Web of Science ®Google Scholar
• Sakakura C, Hagiwara A, Fukuda K, et al. Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers. Anticancer Res. 2003 Sep-Oct;23(5A):3691–3697.
   PubMed Web of Science ®Google Scholar
• Moy RH, Nguyen A, Loo JM, et al. Functional genetic screen identifies ITPR3/calcium/RELB axis as a driver of colorectal cancer metastatic liver colonization. Dev Cell. 2022 May 9;57(9):1146–1159 e7. doi: 10.1016/j.devcel.2022.04.010
   PubMed Web of Science ®Google Scholar
• Szatkowski C, Parys JB, Ouadid-Ahidouch H, et al. Inositol 1,4,5-trisphosphate-induced Ca2+ signalling is involved in estradiol-induced breast cancer epithelial cell growth. Mol Cancer. 2010 Jun 21;9(1):156. doi: 10.1186/1476-4598-9-156
   PubMedGoogle Scholar